AP – A new study raises fresh concerns about Zetia and its cousin, Vytorin — drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.
Excerpt from:
Study raises new questions about Merck pill Zetia
(AP)
Similar Posts:
- Merck earnings dive on year-ago gains, lower sales – MarketWatch
- Abortion pill used in a quarter of US abortions
(AP) - Once-a-day heart combo pill shows promise in study
(AP) - Statins May Not Protect Against Pneumonia
(HealthDay) - One Size Fits All? New Pill Combines Heart Drugs
- FDA weighs approval of psychiatric drugs for kids
(AP)
Study raises new questions about Merck pill Zetia (AP)
If you enjoyed this post, make sure you subscribe to my RSS feed!
Leave a comment